Development and validation of a UV spectroscopic method to estimate etoricoxib in bulk and tablet formulation

Garlapati Manideep, Nazare Lobo John Shane, Girish Pai, Muddukrishna Badamane Sathyanarayana

Research output: Contribution to journalArticle

Abstract

This present UV Spectrophotometric method developed using methanol as a solvent is simple, rapid, specific, precise and sensitive to estimation Etoricoxib in bulk in day to day analysis. The method was validated as per ICH Q2R1 guideline. Etoricoxib is the newest addition to the group of Non-Steroidal Anti-Inflammatory Drugs-highly selective COX-2 inhibitor. The solvent used in the entire method development and validation was methanol. The maximum wavelength of absorption was found to be 234nm. Beer’s law was obeyed in the concentration range of 1 to 11µg/mL with correlation coefficient of 0.9986. The method was precise with an RSD of0.42%the LOD and LOQ were found to be 0.09µg/ml and 0.2µg/ml respectively. The method was validated for precision, linearity, accuracy and robustness and all parameters were found to be satisfactory which proves that this method can be used for routine analysis of Etoricoxib.

Original languageEnglish
Pages (from-to)758-760
Number of pages3
JournalResearch Journal of Pharmacy and Technology
Volume11
Issue number2
DOIs
Publication statusPublished - 01-02-2018

Fingerprint

etoricoxib
Tablets
Methanol
Cyclooxygenase 2 Inhibitors
Anti-Inflammatory Agents

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Pharmacology (medical)

Cite this

@article{a4a56595ee7f4ce9bcccf40a51bd8052,
title = "Development and validation of a UV spectroscopic method to estimate etoricoxib in bulk and tablet formulation",
abstract = "This present UV Spectrophotometric method developed using methanol as a solvent is simple, rapid, specific, precise and sensitive to estimation Etoricoxib in bulk in day to day analysis. The method was validated as per ICH Q2R1 guideline. Etoricoxib is the newest addition to the group of Non-Steroidal Anti-Inflammatory Drugs-highly selective COX-2 inhibitor. The solvent used in the entire method development and validation was methanol. The maximum wavelength of absorption was found to be 234nm. Beer’s law was obeyed in the concentration range of 1 to 11µg/mL with correlation coefficient of 0.9986. The method was precise with an RSD of0.42{\%}the LOD and LOQ were found to be 0.09µg/ml and 0.2µg/ml respectively. The method was validated for precision, linearity, accuracy and robustness and all parameters were found to be satisfactory which proves that this method can be used for routine analysis of Etoricoxib.",
author = "Garlapati Manideep and Shane, {Nazare Lobo John} and Girish Pai and Sathyanarayana, {Muddukrishna Badamane}",
year = "2018",
month = "2",
day = "1",
doi = "10.5958/0974-360X.2018.00142.7",
language = "English",
volume = "11",
pages = "758--760",
journal = "Research Journal of Pharmacy and Technology",
issn = "0974-3618",
publisher = "A and V Publication",
number = "2",

}

Development and validation of a UV spectroscopic method to estimate etoricoxib in bulk and tablet formulation. / Manideep, Garlapati; Shane, Nazare Lobo John; Pai, Girish; Sathyanarayana, Muddukrishna Badamane.

In: Research Journal of Pharmacy and Technology, Vol. 11, No. 2, 01.02.2018, p. 758-760.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and validation of a UV spectroscopic method to estimate etoricoxib in bulk and tablet formulation

AU - Manideep, Garlapati

AU - Shane, Nazare Lobo John

AU - Pai, Girish

AU - Sathyanarayana, Muddukrishna Badamane

PY - 2018/2/1

Y1 - 2018/2/1

N2 - This present UV Spectrophotometric method developed using methanol as a solvent is simple, rapid, specific, precise and sensitive to estimation Etoricoxib in bulk in day to day analysis. The method was validated as per ICH Q2R1 guideline. Etoricoxib is the newest addition to the group of Non-Steroidal Anti-Inflammatory Drugs-highly selective COX-2 inhibitor. The solvent used in the entire method development and validation was methanol. The maximum wavelength of absorption was found to be 234nm. Beer’s law was obeyed in the concentration range of 1 to 11µg/mL with correlation coefficient of 0.9986. The method was precise with an RSD of0.42%the LOD and LOQ were found to be 0.09µg/ml and 0.2µg/ml respectively. The method was validated for precision, linearity, accuracy and robustness and all parameters were found to be satisfactory which proves that this method can be used for routine analysis of Etoricoxib.

AB - This present UV Spectrophotometric method developed using methanol as a solvent is simple, rapid, specific, precise and sensitive to estimation Etoricoxib in bulk in day to day analysis. The method was validated as per ICH Q2R1 guideline. Etoricoxib is the newest addition to the group of Non-Steroidal Anti-Inflammatory Drugs-highly selective COX-2 inhibitor. The solvent used in the entire method development and validation was methanol. The maximum wavelength of absorption was found to be 234nm. Beer’s law was obeyed in the concentration range of 1 to 11µg/mL with correlation coefficient of 0.9986. The method was precise with an RSD of0.42%the LOD and LOQ were found to be 0.09µg/ml and 0.2µg/ml respectively. The method was validated for precision, linearity, accuracy and robustness and all parameters were found to be satisfactory which proves that this method can be used for routine analysis of Etoricoxib.

UR - http://www.scopus.com/inward/record.url?scp=85049335147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049335147&partnerID=8YFLogxK

U2 - 10.5958/0974-360X.2018.00142.7

DO - 10.5958/0974-360X.2018.00142.7

M3 - Article

AN - SCOPUS:85049335147

VL - 11

SP - 758

EP - 760

JO - Research Journal of Pharmacy and Technology

JF - Research Journal of Pharmacy and Technology

SN - 0974-3618

IS - 2

ER -